UK markets closed

Epigenomics AG (EPGNY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
14.370.00 (0.00%)
At close: 9:43AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.37
Open14.37
Bid0.00 x 0
Ask0.00 x 0
Day's range14.37 - 14.37
52-week range7.00 - 159.16
Volume6
Avg. volume17
Market cap33.98M
Beta (5Y monthly)1.12
PE ratio (TTM)N/A
EPS (TTM)-7.09
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date16 Sept 2021
1y target estN/A
  • EQS Group

    Epigenomics AG: EVP of Finance Albert Weber leaves the Company

    DGAP-News: Epigenomics AG / Key word(s): Personnel07.10.2021 / 08:00 The issuer is solely responsible for the content of this announcement.Epigenomics AG: EVP of Finance Albert Weber leaves the CompanyBerlin (Germany) and San Diego, CA (U.S.A.), October 7, 2021 - Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the "Company") announces that Executive Vice President Finance Albert Weber will resign from his position as member of the Executive Board of Epigenomics AG as of December 31,

  • EQS Group

    Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million

    DGAP-News: Epigenomics AG / Key word(s): Bond/Issue of Debt13.09.2021 / 13:24 The issuer is solely responsible for the content of this announcement.NOT TO BE PUBLISHED, DISSEMINATED OR PASSED ON TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA AND SOUTH AFRICAPress ReleaseEpigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 millionBerlin, September 13, 2021 - Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the "Compan

  • EQS Group

    Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance

    Epigenomics AG / Key word(s): Strategic Company Decision/Change in ForecastEpigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance17-Aug-2021 / 21:00 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Epigenomics AG: Execution of a Biobank Sale Agreement and Update of GuidanceBerlin, Germany, August 17, 2021